The event organizers selected Raleigh for their inaugural event given the Triangle region’s reputation for being an important ...

Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...

Bartonella are small bacteria that can cause big health problems. Pervasive in the environment and difficult to detect, they can persist in the body for weeks or months unnoticed before causing ...

North Carolina’s Research Triangle region is the nation’s fourth leading hub for biotechnology activity, trailing only Boston, San Francisco and San Diego, says Fierce Biotech, an online publication ...

Arbiom, an agricultural biotechnology company based in Durham, says on its website, “We’re already using wood for our buildings, furniture, floors and more. Why not re-imagine wood as food?” The ...

E. Norris Tolson, president and CEO of the North Carolina Biotechnology Center, will discuss the rewards and challenges confronting the state's wide-ranging biotechnology sector at a breakfast for ...

North Carolina’s global leadership in biomanufacturing has drawn another spotlight with a White House announcement that President Donald Trump will be visiting the Triangle on Monday, July 27, to a ...

Durham-based Humacyte, founded by three female scientists in 2004, has received marketing approval from the U.S. Food and ...

Pancreatic cancer is an elusive and deadly disease. It often has no initial symptoms, and there are no reliable tests for early detection. The mortality rate is 75 percent within a year of diagnosis, ...

Pappas Capital, a Durham-based investor in early-stage life sciences companies, has appointed Karen LeVert as venture partner. She will help expand the firm’s Specialized Fund Management business – ...